-
Something wrong with this record ?
Glutamate carboxypeptidase II: an overview of structural studies and their importance for structure-based drug design and deciphering the reaction mechanism of the enzyme
J. Pavlícek, J. Ptácek, C. Barinka,
Language English Country Netherlands
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
- MeSH
- Glutamate Carboxypeptidase II antagonists & inhibitors chemistry genetics metabolism MeSH
- Enzyme Inhibitors chemistry pharmacology MeSH
- Protein Conformation MeSH
- Crystallography, X-Ray MeSH
- Humans MeSH
- Models, Molecular MeSH
- Polymorphism, Genetic MeSH
- Drug Design MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
Recent years witnessed rapid expansion of our knowledge about structural features of human glutamate carboxypeptidase II (GCPII). There are over thirty X-ray structures of human GCPII (and of its close ortholog GCPIII) publicly available at present. They include structures of ligand-free wild-type enzymes, complexes of wild-type GCPII/GCPIII with structurally diversified inhibitors as well as complexes of the GCPII(E424A) inactive mutant with several substrates. Combined structural data were instrumental for elucidating the catalytic mechanism of the enzyme. Furthermore the detailed knowledge of the GCPII architecture and protein-inhibitor interactions offers mechanistic insight into structure-activity relationship studies and can be exploited for the rational design of novel GCPII-specific compounds. This review presents a summary of structural information that has been gleaned since 2005, when the first GCPII structures were solved.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12034757
- 003
- CZ-PrNML
- 005
- 20121207093136.0
- 007
- ta
- 008
- 121023s2012 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2174/092986712799462667 $2 doi
- 035 __
- $a (PubMed)22304708
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Pavlícek, J $u Institute of Biotechnology AS CR, v.v.i., Laboratory of Structural Biology, Videnska 1083, 14200 Praha 4, Czech Republic.
- 245 10
- $a Glutamate carboxypeptidase II: an overview of structural studies and their importance for structure-based drug design and deciphering the reaction mechanism of the enzyme / $c J. Pavlícek, J. Ptácek, C. Barinka,
- 520 9_
- $a Recent years witnessed rapid expansion of our knowledge about structural features of human glutamate carboxypeptidase II (GCPII). There are over thirty X-ray structures of human GCPII (and of its close ortholog GCPIII) publicly available at present. They include structures of ligand-free wild-type enzymes, complexes of wild-type GCPII/GCPIII with structurally diversified inhibitors as well as complexes of the GCPII(E424A) inactive mutant with several substrates. Combined structural data were instrumental for elucidating the catalytic mechanism of the enzyme. Furthermore the detailed knowledge of the GCPII architecture and protein-inhibitor interactions offers mechanistic insight into structure-activity relationship studies and can be exploited for the rational design of novel GCPII-specific compounds. This review presents a summary of structural information that has been gleaned since 2005, when the first GCPII structures were solved.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a krystalografie rentgenová $7 D018360
- 650 _2
- $a racionální návrh léčiv $7 D015195
- 650 _2
- $a inhibitory enzymů $x chemie $x farmakologie $7 D004791
- 650 _2
- $a glutamátkarboxypeptidasa II $x antagonisté a inhibitory $x chemie $x genetika $x metabolismus $7 D043425
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a molekulární modely $7 D008958
- 650 _2
- $a polymorfismus genetický $7 D011110
- 650 _2
- $a konformace proteinů $7 D011487
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Ptácek, J
- 700 1_
- $a Barinka, C
- 773 0_
- $w MED00001274 $t Current medicinal chemistry $x 1875-533X $g Roč. 19, č. 9 (2012), s. 1300-9
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22304708 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a
- 990 __
- $a 20121023 $b ABA008
- 991 __
- $a 20121207093210 $b ABA008
- 999 __
- $a ok $b bmc $g 956767 $s 792254
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 19 $c 9 $d 1300-9 $i 1875-533X $m Current medicinal chemistry $n Curr Med Chem $x MED00001274
- LZP __
- $a Pubmed-20121023
